Strategies to improve self-care of metabolic diseases in the community of Zuleta-Imbabura
DOI:
https://doi.org/10.35381/s.v.v8i2.4250Keywords:
Hypertension, hypertension malignant, hypertension renal, (Source: DeCS)Abstract
Objective: To analyze the prevalence of metabolic diseases in the community of Zuleta. Methods: Descriptive observational study. Results: The population manifested that they suffer from arterial hypertension with 41%, followed by diabetes mellitus with 21%, 17% suffer from obesity, 9% hypercholesterolemia, 7% hypertriglyceridemia, followed by 3% hypothyroidism, and finally, 2% hyperthyroidism. Conclusion: The results obtained in the Zuleta community show a high prevalence of metabolic diseases, especially arterial hypertension and diabetes, affecting men and older adults to a greater extent. Deficiencies in dietary habits, low frequency of physical activity and limited regular medical control are key factors contributing to this problem; genetic predisposition and family history of hypertension increase the risk of future complications.
Downloads
References
Tousoulis D. Arterial hypertension: New concepts in diagnosis and treatment?. Hellenic J Cardiol. 2020;61(3):145-147. http://dx.doi.org/10.1016/j.hjc.2020.08.003
Al Ghorani H, Götzinger F, Böhm M, Mahfoud F. Arterial hypertension - Clinical trials update 2021. Nutr Metab Cardiovasc Dis. 2022;32(1):21-31. http://dx.doi.org/10.1016/j.numecd.2021.09.007
Jordan J, Kurschat C, Reuter H. Arterial Hypertension. Dtsch Arztebl Int. 2018;115(33-34):557-568. http://dx.doi.org/10.3238/arztebl.2018.0557
Lee JH, Kim KI, Cho MC. Current status and therapeutic considerations of hypertension in the elderly. Korean J Intern Med. 2019;34(4):687-695. http://dx.doi.org/10.3904/kjim.2019.196
Di Palo KE, Barone NJ. Hypertension and Heart Failure: Prevention, Targets, and Treatment. Heart Fail Clin. 2020;16(1):99-106. http://dx.doi.org/10.1016/j.hfc.2019.09.001
Slivnick J, Lampert BC. Hypertension and Heart Failure. Heart Fail Clin. 2019;15(4):531-541. http://dx.doi.org/10.1016/j.hfc.2019.06.007
Hansson L. The Hypertension Optimal Treatment study and the importance of lowering blood pressure. J Hypertens Suppl. 1999;17(1):S9-S13.
Ekbom T, Linjer E, Hedner T, et al. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2. Blood Press. 2004;13(3):137-141. http://dx.doi.org/10.1080/08037050410014944
Pont L, Alhawassi T. Challenges in the Management of Hypertension in Older Populations. Adv Exp Med Biol. 2017;956:167-180. http://dx.doi.org/10.1007/5584_2016_149
Filipovský J. Arterial hypertension in the elderly. Arteriální hypertenze ve stáří. Vnitr Lek. 2018;64(11):987-992.
Gopar-Nieto R, Ezquerra-Osorio A, Chávez-Gómez NL, Manzur-Sandoval D, Raymundo-Martínez GIM. How to treat hypertension? Current management strategies [¿Cómo tratar la hipertensión arterial sistémica? Estrategias de tratamiento actuales]. Arch Cardiol Mex. 2021;91(4):493-499. Published 2021 Nov 1. http://dx.doi.org/10.24875/ACM.200003011
Comité Nacional de Nefrología; Comité de Estudios Feto Neonatales (CEFEN). Hipertensión arterial en el recién nacido [Arterial hypertension in the newborn]. Arch Argent Pediatr. 2020;118(6):S153-S163. http://dx.doi.org/10.5546/aap.2020.S153
Strizhakov LA, Babanov SA, Lebedeva MV, Moiseev SV, Fomin VV. Arterial hypertension at the workplace: risk factors and the population value. Ter Arkh. 2018;90(9):138-143. http://dx.doi.org/10.26442/terarkh2018909138-143
Chazova IE. Arterial hypertension in the light of current recommendations. Ter Arkh. 2018;90(9):4-7. http://dx.doi.org/10.26442/terarkh20189094-7
Luna-López R, Ruiz Martín A, Escribano Subías P. Pulmonary arterial hypertension. Hipertensión arterial pulmonar. Med Clin (Barc). 2022;158(12):622-629. http://dx.doi.org/10.1016/j.medcli.2022.01.003
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Jessica Rocio Acosta-Cadena, Andrea Carolina Alarcón-Troya, José Gabriel Guerrero-Játiva, Melba Esperanza Narváez-Jaramillo
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
